Saniona
7.68
SEK
-1.54 %
SANION
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-1.54%
+8.78%
-4.48%
+99.22%
+76.55%
+273.72%
+2.91%
-69.13%
+96.1%
Saniona is active in biotechnology. Today, research and development of drugs for the treatment of nerve diseases and other autoimmune diseases are conducted. The drug portfolio is broad and includes drugs that are currently in various clinical phases. Some of the work is also carried out in collaboration with other cooperation partners in the pharmaceutical industry. Saniona is headquartered in Glostrup.
Read moreMarket cap
864.25M SEK
Turnover
2.46M SEK
Revenue
16.84M
EBIT %
-481.41 %
P/E
-
Dividend yield-%
-
Financial calendar
27.2
2025
Annual report '24
28.5
2025
General meeting '25
28.5
2025
Interim report Q1'25
ShowingAll content types
BioStock: Saniona-backed Cephagenix secures 9 MEUR in seed financing
Saniona’s Joint Venture, Cephagenix, Secures Seed Funding from AdBio Partners and AbbVie Ventures
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools